Prokidney to participate in a fireside chat at the upcoming evercore isi 6th annual healthconx conference

Winston-salem, n.c, nov. 21, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company”), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients living with chronic kidney disease (ckd), today announced that management will be participating in a fireside chat at the 6th annual evercore isi healthconx conference being held in miami, florida on november 28-30, 2023.
PROK Ratings Summary
PROK Quant Ranking